• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Pear Therapeutics

Pear Therapeutics closes $80M Series D

December 9, 2020 By Sean Whooley

Substance use and opioid use treatment developer Pear Therapeutics announced that it closed an $80 million Series D financing round. Existing investors Temasek, 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, CrimsoNox and EDBI contributed, as did new investors Forth Management, Pilot House, Sarissa Capital, Shanda Group, and QUAD Investment Management, according to a news release. Get […]

Filed Under: Business/Financial News, Drug-Device Combinations, Funding Roundup Tagged With: Pear Therapeutics

The 18 most innovative medical devices of 2020

July 24, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Endoscopic, Featured, Implants, Oncology, Pain Management, Patient Monitoring, Respiratory, Structural Heart, Vascular, Vision Tagged With: Abbott, BD, Biotronik, Boston Scientific, Edwards Lifesciences, endomag, Glaukos, Impulse Dynamics, Medtronic, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, Teva Pharmaceuticals

Novartis unit spikes Pear Therapeutics deal

October 17, 2019 By Sean Whooley

Novartis (NYSE:NVS) unit Sandoz said this week that Pear Therapeutics will take sole responsibility for the commercialization of their prescription digital therapeutics program for treating substance and opioid use disorders. In April 2018, Pear announced that it agreed to deal commercialization rights of its digital therapeutics to Sandoz. The companies did not disclose financial details, but […]

Filed Under: Business/Financial News, Pharmaceutical Tagged With: Novartis, Pear Therapeutics, sandoz

The 17 most innovative medical devices of 2019

July 18, 2019 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 13th Annual Prix Galien USA Awards. The foundation awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Nominees need to be FDA approved for market within the last five […]

Filed Under: Cardiac Implants, Cardiovascular, Drug-Device Combinations, Featured, Implants, Neuromodulation/Neurostimulation, News Well, Research & Development, Stents Tagged With: Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Endomagnetics, Glaukos, humanoptics, Lynch Biologics, Medtronic, Pear Therapeutics, Pulmonx, Sonendo, starkey, Teva Pharmaceuticals

Sandoz, Pear launch digital therapy for opioid use disorder

January 8, 2019 By Sarah Faulkner

Novartis (NYSE:NVS) division Sandoz and Pear Therapeutics this week kicked off the U.S. commercial launch of the first FDA-cleared prescription digital therapy for people with opioid use disorder. The companies partnered to commercialize a 12-week cognitive behavioral therapy intended to be used in tandem with outpatient treatment. The therapy includes transmucosal buprenorphine and contingency management designed to reinforce positive behaviors, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Neurological, Pharmaceutical, Wall Street Beat Tagged With: Pear Therapeutics, sandoz

Pear Therapeutics wins FDA nod for digital opioid addiction treatment app

December 17, 2018 By Danielle Kirsh

Pear Therapeutics has received FDA 510(k) clearance for its reSET-O medical application that helps treat patients who have an opioid use disorder. The reSET-O app is a prescription cognitive behavioral therapy that is designed to be used with outpatient treatment and under the care of a healthcare professional. It is also designed to be used […]

Filed Under: 510(k), Regulatory/Compliance Tagged With: Pear Therapeutics

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS